MC
VIVO

Menta Capital’s Meridian Bioscience Inc VIVO Stock Holding History

Menta Capital’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$122K Hold
10,232
– – 0.05% 433
2019
Q1 		$180K Hold
10,232
– – 0.08% 401
2018
Q4 		$178K Sell
10,232
-12,470
-55% -$213K 0.07% 444
2018
Q3 		$338K Buy
22,702
+24
+0.1% +$372 0.12% 345
2018
Q2 		$361K Hold
22,678
– – 0.08% 421
2018
Q1 		$322K Hold
22,678
– – 0.07% 453
2017
Q4 		$317K Sell
22,678
-2,907
-11% -$42.6K 0.06% 482
2017
Q3 		$366K Sell
25,585
-25,100
-50% -$359K 0.05% 569
2017
Q2 		$798K Sell
50,685
-13,116
-21% -$189K 0.09% 387
2017
Q1 		$880K Sell
63,801
-39,150
-38% -$547K 0.09% 393
2016
Q4 		$1.82M Buy
102,951
+26,313
+34% +$462K 0.15% 216
2016
Q3 		$1.48M Sell
76,638
-45,810
-37% -$897K 0.14% 251
2016
Q2 		$2.39M Buy
122,448
+24,739
+25% +$485K 0.33% 37
2016
Q1 		$2.01M Sell
97,709
-34,935
-26% -$688K 0.28% 65
2015
Q4 		$2.72M Buy
132,644
+8,304
+7% +$159K 0.35% 47
2015
Q3 		$2.13M Sell
124,340
-1,172
-0.9% -$21.4K 0.34% 60
2015
Q2 		$2.34M Buy
125,512
+11,600
+10% +$215K 0.38% 38
2015
Q1 		$2.17M Sell
113,912
-62,900
-36% -$1.16M 0.28% 120
2014
Q4 		$2.91M Buy
176,812
+49,790
+39% +$854K 0.41% 55
2014
Q3 		$2.25M Buy
127,022
+96,622
+318% +$1.9M 0.37% 75
2014
Q2 		$627K Buy
+30,400
New +$625K 0.12% 244
2014
Q1 		– Sell
-12,900
Closed -$342K – 466
2013
Q4 		$342K Sell
12,900
-2,600
-17% -$63.9K 0.14% 216
2013
Q3 		$366K Buy
15,500
+2,000
+15% +$46.7K 0.19% 189
2013
Q2 		$290K Buy
+13,500
New +$291K 0.19% 232

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Menta Capital's VIVO Position: Q2 2019 in Review

Menta Capital held its Meridian Bioscience Inc (VIVO) position steady in Q2 2019 at 10,232 shares worth $122K. The position accounts for 0.05% of the portfolio, ranked #433.

Menta Capital first reported a position in VIVO in Q2 2013 and has held it in 24 quarters since. The position peaked at $2.91M in Q4 2014. 173 funds tracked by Wall St. Rank hold VIVO as of Q2 2019.

  • Menta Capital held 10,232 shares of Meridian Bioscience Inc worth $122K as of Q2 2019.
  • Menta Capital left its Meridian Bioscience Inc share count unchanged in Q2 2019.
  • Meridian Bioscience Inc made up 0.05% of Menta Capital's portfolio in Q2 2019, its #433 holding.
  • Menta Capital first reported a position in Meridian Bioscience Inc in Q2 2013 and has held it in 24 quarters since.
  • Menta Capital's Meridian Bioscience Inc position peaked at $2.91M in Q4 2014.
  • 173 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2019.

Based on Menta Capital's 13F filing for Q2 2019, filed 7 Aug 2019.